From vaccines and AI innovations to imminent breakthroughs, discover the cutting-edge advancements shaping the future of healthcare in this conversation with radio host Mark Hahn.
CRISPR
In this wide-ranging radio conversation, Mark Hahn and I discuss the spectrum of genetic modification, including the use of CRISPR technology to enhance the resistance of bird flocks, such as chickens and turkeys, against diseases like Avian Influenza.
Editors at the journal Nature Medicine recently asked researchers and public health experts from around the world to identify clinical trials that will shape medicine in 2023. They came up with a varied list of candidates, from cervical and prostate cancer screening protocols to gene therapy for muscular dystrophy and new drugs for Parkinson’s disease and Alzheimer’s disease. The selections are arbitrary and idiosyncratic, but they are interesting, nevertheless.
The activist group GM has attacked gene-edited crops by alleging that they're designed to increase pesticide use. Is there any truth to this allegation? With millions of COVID vaccine doses administered since December 2020, what have we learned about the risks associated with the shots?
The Non-GMO Project recently reassured its Twitter followers that seedless watermelon is not genetically modified. The only problem is that this delicious summer treat is a "GMO"—and it undermines the project's dubious business model.
Do biotech companies lie about the pesticide-saving benefits of genetically engineered crops? The activist group GM Watch says yes. Do they have a convincing case? Nope.
A recent study examined the nutritional composition of meat and milk derived from gene-edited cattle bred to be hornless. The two-year-long project provided further evidence vindicating the safe use of biotechnology in food production.
Britain may soon approve a gene-edited tomato that boosts vitamin D intake. Let's take a look at the science and politics surrounding this important development.
Should organic farmers grow gene-edited crops? A leading figure in the agroecology movement says "yes"—and so does the generation of environmentalists following in his footsteps.
It's time for the UK to embrace the benefits of crop biotechnology to boost its farm sector. I make the case in a recent report for the Adam Smith Institute.
Disease-resistant grapes are among the many genetically engineered plants that have yet to be commercialized. They would help the wine industry cut its pesticide use and expand production, lowering costs for both winemakers and consumers. Why haven't these GE grapes been approved?
Some scientists say we need tighter gene-editing regulations to mitigate the serious risks associated with the technology. There are some critical flaws in their argument.